Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript May 8, 2023
Enanta Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.79, expectations were $-1.98.
Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Second Quarter Ended March 31, 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode. There will be a question-and-answer session at the end of prepared remarks. Please be advised that...
